Healer

Healer concentrated 87.67% of June 2026 sales in Tincture & Sublingual, where year-over-year sales fell 71.61% and month-over-month dipped 1.33%, while Capsules, at a 4.73% share, expanded 455.88% YoY and 147.01% MoM. Topical held a 4.92% share with a 44.72% YoY decline but a 77.93% MoM jump, and Edible accounted for 2.68% share with a 28.60% MoM decrease and no YoY comp; combined with a 17.83% YoY increase in average price, the mix indicates demand is consolidating in the legacy tincture base even as smaller formats begin to re-activate. The pattern implies a reliance on a shrinking core while fast-growing Capsules and a recovering Topical offer early diversification signals that have not yet offset the broader 68.61% YoY brand sales contraction.

With Tincture & Sublingual still ranking number 2 in Maryland, Healer retains positional relevance in its core even as the category’s 71.61% YoY slide compresses volume, suggesting near-term share defense paired with selective expansion. The 147.01% MoM surge in Capsules alongside a 77.93% MoM gain in Topical, against a simultaneous 1.33% MoM decline in the dominant tincture line and a 28.60% MoM drop in Edible, indicates the most efficient path to stabilize revenue is to tilt assortment and merchandising toward Capsules and Topical while calibrating price architecture (up 17.83% YoY) to protect rank without further dampening conversion.